Sitemap

Nicole Dale

FDA Clinical Trial Oversight Tightens Globally

FDA clinical trial oversight is intensifying globally as the agency raises expectations for GCP, foreign site inspections, data integrity, and patient protection.

Nicole Dale

MHRA Updates GCP Inspection Guidance for ICH E6(R3)

Pharmatica image of a bright clinical research setting representing MHRA GCP inspection readiness, trial master file access, and regulatory oversight.

The MHRA GCP inspection guidance now reflects ICH E6(R3) and the UK’s 2026 trials reform, with a new computerised systems dossier and clear TMF access rules.

Nicole Dale

How Low Can They Go? Clinical Trial Success Rates

Clinical laboratory automation platform used in drug development research, illustrating factors that influence Clinical Trial Success Rates, including advanced manufacturing technologies, precision workflows, and pharmaceutical innovation.

Clinical trial success rates have declined sharply over the past 20 years. This analysis examines what the data reveals about the drug approval rate and phase-by-phase attrition.

Nicole Dale

11 Clinical Trials Defining Pharmaceutical Strategy in 2026

The top 11 clinical trials 2026 highlighting breakthrough pharmaceutical innovations across obesity, gene editing, cardiovascular disease, psychiatry, and rare diseases.

We've mapped the competitive, regulatory, and commercial stakes of the top 11 clinical trials that have defined pharma strategy so far in 2026.

Nicole Dale

Eli Lilly and AtaiBeckley: AI and Psychedelic Biotech Converge

Pharmatica image showing an anatomically accurate human brain with subtle neural activation inspired by functional MRI imaging, representing psychedelic biotech, mental health therapeutics, CNS drug discovery, and AI-enabled pharmaceutical innovation.

Eli Lilly's acquisition of Peter Thiel’s backed AtaiBeckley highlights growing investment in psychedelic biotech and the future of CNS drug discovery.

Nicole Dale

Psychedelic Drug Discovery Gets a New Preclinical Framework

Pharmatica detailed rendering of a neuron firing electrical impulses through dendrites and axons in vivid green tones, symbolising neural connectivity and communication in psychedelic drug discovery, neuroplasticity, 5-HT2A receptor pharmacology, CNS drug development, psychoplastogens, and therapeutic neuroscience research.

Find out how psychedelic drug discovery is evolving through receptor pharmacology, behavioural science, and neuroplasticity to develop safer CNS therapeutics.